Partners of Sughrue Mion PLLC , a global intellectual property law firm, recently addressed the impact of new U.S. patent legislation on international markets at the 2012 BIO KOREA Health for Humanity Conference held in Seoul, Korea on September 12-14.
The 7th Annual BIO KOREA Conference focused on a diverse range of applications and areas such as medical care, food, agriculture, energy, chemicals, and the environment. Several Sughrue Mion partners led the track on IP Legal Matters, discussing the impact of the latest patent legislation overhaul on the biologics and pharmaceutical industries.
Presentations included “The Challenges of Inter Partes Review for Pharma and Bio Companies” by Mike Dzwonczyk; “Successful IP Strategies for Biotech Platforms Technologies” by Karen Dow; “Post Grant Review Under the America Invents Act (AIA)” by Chid Iyer; and “Challenges on Patent Protection of Diagnostic Method and Personalized Treatment Methods in the U.S.” by Sunhee Lee.
The three-day conference hosted approximately 4,500 representatives from the bio industry, research institutes, and academic organizations, as well as interested individuals from Korea and throughout the world. Established in 2006, the annual BIO KOREA conference is now the most influential and best-known event of its kind in Asia. The conference provides an opportunity for domestic and foreign investors to meet fast-growing Korean bio companies and leading Korean research institutions.
Sughrue Mion’s participation in this year’s BIO KOREA Health for Humanity Conference is one of many examples of the firm’s commitment to providing education and counsel on diverse intellectual property topics.
In addition to several events in Europe and Asia this fall, Sughrue Mion will host the inaugural Robert Shaw International Intellectual Property Symposium on International IP Practice and the America Invents Act.
The event will occur at the University of New Hampshire on April 25, 2013.